Asia · Regional markets · CNBC-TV18

Ajanta Pharma Q2 Results: Net profit rises 49% to ₹388 crore, revenue up 33%

Published by CNBC-TV18 · India 2 h ago

At the operating level, the company reported EBITDA of ₹547.6 crore for the quarter. Its EBITDA margin expanded to 30.5% from 24.2% in the corresponding period last year.

Read the full article on CNBC-TV18 Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

The Straits Times Business

Ajanta Pharma Q2 Results: Net profit rises 49% to ₹388 crore, revenue up 33%

Share

Also worth reading

Foxconn working on a new tie-up with OpenAI, says there is no AI bubble

Init 6 invests in Indonesian AI infra startup Netra Runtime

Nifty Pharma index hits record high; Sun, Laurus, Zydus, Sai rally up to 6%

Who are some of the longest-serving CEOs among Singapore’s blue-chip companies?

Czech nuclear dispute must not undermine Team Korea’s global credibility

China Evergrande Strikes USD513 Million Deal to Offload Key Profitable Unit Amid Liquidation